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Abstract
Background: Many countries have made significant progress in the implementation of World Health Organization
recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges
such as the existence of areas of residual infections in disease endemic districts pose potential threats to the
achievements made. Thus, this study was undertaken to assess the importance of these areas in implementation
units (districts) where microfilaria (MF) positive individuals could not be found during the mid-term assessment
after three rounds of mass drug administration.
Methods: This study was undertaken in Bo and Pujehun, two LF endemic districts of Sierra Leone, with baseline
MF prevalence of 2 % and 0 % respectively in sentinel sites for monitoring impact of the national programme.
Study communities in the districts were purposefully selected and an assessment of LF infection prevalence was
conducted together with entomological investigations undertaken to determine the existence of areas with
residual MF that could enable transmission by local vectors. The transmission Assessment Survey (TAS) protocol
described by WHO was applied in the two districts to determine infection of LF in 6–7 year old children who
were born before MDA against LF started.
Results: The results indicated the presence of MF infected children in Pujehun district. An. gambiae collected in
the district were also positive for W. bancrofti, even though the prevalence of infection was below the threshold
associated with active transmission.
Conclusions: Residual infection was detected after three rounds of MDA in Pujehun – a district of 0 % Mf
prevalence at the sentinel site. Nevertheless, our results showed that the transmission was contained in a small
area. With the scale up of vector control in Anopheles transmission zones, some areas of residual infection may
not pose a serious threat for the resurgence of LF if the prevalence of infections observed during TAS are below
the threshold required for active transmission of the parasite. However, robust surveillance strategies capable of
detecting residual infections must be implemented, together with entomological assessments to determine if
ongoing vector control activities, biting rates and infection rates of the vectors can support the transmission of
the disease. Furthermore, in areas where mid-term assessments reveal MF prevalence below 1 % or 2 % antigen
level, in Anopheles transmission areas with active and effective malaria vector control efforts, the minimum 5
rounds of MDA may not be required before implementing TAS. Thus, we propose a modification of the WHO
recommendation for the timing of sentinel and spot-check site assessments in national programs.
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Background
The Global Program to Eliminate Lymphatic Filariasis
(GPELF) targets the elimination of LF as a public health
problem by the year 2020, through mass drug adminis-
tration (MDA) in endemic implementation units (IU),
with the aim of interrupting transmission and stopping
the spread of infection in all endemic areas. [1]. While
many countries have made significant progress in reducing
transmission intensity and incidence of infection through
community-wide treatments, there remain significant pro-
grammatic challenges to interrupting parasite transmission.
These include effective implementation of the preventive
chemotherapy strategy in urban settings, [2, 3] and the ex-
istence of areas of residual infection [4–6] that may precipi-
tate the spread of infection after the conditions for stopping
MDA have been met [7, 8].
Implementing MDA is a critical challenge for the GPELF,
especially in countries affected by conflict. Among the four
LF endemic countries (Sierra Leone, Liberia, Guinea and
Cote d’Ivoire) recently affected by conflict in West Africa,
only Sierra Leone was implementing MDA (with Ivermec-
tin and Albendazole) in 2011. All 14 districts in Sierra
Leone were endemic for LF antigen before MDA started in
2008 [9, 10]. Nevertheless, after three rounds of treatment
(2008–2010), a midterm progress evaluation following
WHO guidelines revealed that the microfilaria prevalence
in people five years and older was reduced to 0 % in five
districts [9]. The other nine districts had microfilaria
(MF) prevalence below 1 % in sentinel sites with the
exception of one district. The overall average MF preva-
lence, before and after the three MDAs, were 2.4 % and
0.3 % respectively [9].
LF and onchocerciasis are co-endemic in 12 of the 14
districts in Sierra Leone. Prior to the initiation of MDA for
LF in Sierra Leone in 2007, many people in the implemen-
tation units co-endemic for both diseases had received
more than 5 rounds of treatment with Ivermectin through
the community directed intervention (CDI) implemented
by the African Programme for Onchocerciasis Control
(APOC) [11]. Treatment for onchocerciasis and, scaling up
of bed net distribution in Sierra Leone [12, 13] may have
impacted LF prevalence because Ivermectin alone is also
effective against LF [14–16], and treated bed nets dramatic-
ally reduce exposure to mosquito bites [17]. Furthermore,
in Sierra Leone as in other countries in West Africa, LF is
transmitted solely by the malaria carrying Anopheles
mosquitoes [18]. Anopheles-transmitted LF is highly focal
[19–21] and synchronous with intense malaria transmission
[21, 22]. Malaria control efforts targeting Anopheles mos-
quitoes therefore have the potential to significantly impact
on LF transmission in West Africa, as was possibly the case
in the interruption of LF transmission in Togo [23].
WHO recommends that a Transmission Assessment
Survey (TAS) to determine when to stop MDA be carried
out when an implementation unit (District) has completed
five effective rounds of annual MDA and the prevalence
of MF is less than 1 % in all sentinel and spot check sites
in the districts [24]. TAS is based on antigenemia preva-
lence (in children) that may persist after transmission has
been interrupted. Interpretation of these endpoints is also
confounded by the size of the evaluation unit, focality of
the disease and movement of infected individuals from
endemic areas to non-endemic areas. Despite the fact that
Sierra Leone had only implemented three effective rounds
of MDA for LF, this study was undertaken to investigate
the significance of residual infections for the outcome
of TAS in areas of Anopheles-transmitted LF previously
treated with Ivermectin, and with active vector control
activities.
Methods
Ethics statement
Approval for the study was obtained from the ethics
review committee of the Liverpool School of Tropical
Medicine and the Ministry of Health – Sierra Leone.
Prior to conducting the survey and obtaining informed
consent, repeated community meetings were held in all
of the villages to communicate the purposes of the study
and answer questions at the individual and community
level. Informed consent to participate in the study was
obtained from all individuals 18 years or older. Consent
was obtained from a parent or guardian of younger indi-
viduals. Informed consent was also received from mos-
quito collectors, 18 years and above, after which they
were trained in safe and scientifically reliable mosquito
collection. Consent was also sought from the head of the
households where mosquito sampling was carried out.
For the Transmission Assessment Surveys (TAS), the
communities where the schools were located were in-
formed of the purpose of the study, in their local language.
Due to low literacy rates, informed oral consent was ob-
tained from the community leaders, as well as parents and
guardians of each child participating in the study. The
names of consenting parents and their children were
recorded, and only the principal investigators of the study
had access to this information. The data was analysed and
reported, to exclude any directly identifiable information,
in order to maintain the anonymity of the parents and
children.
Study sites
This study was conducted in the Pujehun and Bo Districts
of Sierra Leone. Bo town is the second largest city and an
important mining centre in Sierra Leone, whereas Pujehun
is a less populated, semi-urban area. These districts are
located in the rainforest area in the Southern Province, with
farming as an important socio-economic activity. Baseline
MF (2007–8) and midterm (2011) surveys failed to identify
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any MF positive individual in one of the two districts stud-
ied (Pujehun), which was maintained in this district, and
the number of MF positive individuals in the second district
(Bo) reduced from 2.0 % to zero after three rounds of
MDA [9, 10]. Communities in the districts were visited
to assess their sizes and distances from the district cap-
itals, in order to plan the entomological investigations.
The number of households was determined from the
community data. Based on this information study com-
munities were purposefully selected to maximize the
collection of mosquitoes, taking into consideration lo-
gistic demands. Six communities in the Pujehun Dis-
tricts and four communities in the Bo District were
selected for the study (Table 1). The coordinates of the
communities and distance from the district capital were
recorded using a Garmin Handheld GPS. The map of
the study communities was drawn in ArcGIS version 10
(ESRI).
Sample collection
Assessment for LF prevalence was conducted in the
study communities using the Binax Now ICT card.
Altogether, 1542 individuals were surveyed in the
Pujehun District while 1313 individuals were surveyed
in the Bo District. Samples were collected from indi-
viduals aged between 6–65 years of age.
Entomological surveys were also undertaken to deter-
mine the existence of active transmission in study areas,
and also study the importance of local transmission.
Thus, mosquitoes were collected using the Pyrethrum
Spray method, Exit Traps and Human Landing Collec-
tions, and processed as previously described [25]. Briefly,
DNA was extracted from pooled mosquitoes using the
Qiagen DNeasy tissue kit (Qiagen CA) extraction method.
This was followed by PCR to detect W. bancrofti DNA
using the method of Ramzy and colleagues [26]. A positive
and negative control was included in all reactions and
samples testing positive for W. bancrofti were confirmed
using a second PCR. Positive samples were also confirmed
using the slightly modified loop-mediated isothermal
amplification (LAMP) method for detecting W. bancrofti
DNA [27]. In each household surveyed for mosquitoes,
we collected information on the number of people living
in the house and the number of people who used ITN the
night before the collection. From this information ITN
usage rates were determined for each community.
While this study was not meant to undertake Transmis-
sion Assessment Surveys (TAS) [24], the TAS protocol was
applied in the two districts because it is a statistically strong
method to determine infection prevalence of LF in children
as an indicator of active transmission in the district. TAS
for LF is undertaken to determine whether infection has
been reduced to levels below which transmission cannot be
sustained, allowing for a decision to stop MDA. As such,
children aged 6–7 years were sampled from various schools
selected using the TAS protocol, and tested for LF antigen
and microfilaria. Some schools in the LF assessment sites
formed part of the schools selected using the TAS protocol.
Table 2 TAS summary results for school children in Pujehun and Bo Districts [25]
District No. of Schools No. of Children Surveyed Males (%) Females (%) No. MF Positive No. Ag. Positive (%) Critical Cut-off Value
for Ag positives
Pujehun 31 1503 659 (43.8 %) 844 (56.2 %) 4 10 (0.67 %) 18
Bo 30 1564 682 (43.6 %) 882 (56.4 %) 0 3 (0.16 %) 18
Table 1 Surveillance for LF in study sites in Pujehun and Bo Districts. *Schools in these communities were part of the TAS survey
District Site Females Males Total Tested ICT Positive (%)
Pujehun Sahn Malem 124 226 350 0 (0.0)
Karlu* 188 162 350 1 (0.3)
Gbondapi 192 158 350 3 (0.9)
Sumbuya Bessima 31 32 63 0 (0.0)
Kondorwahun 65 92 157 0 (0.0)
Vaama* 144 127 271 1 (0.4)
Total 744 797 1542 5 (0.3)
Bo Njala Komboya 164 186 350 3 (0.9)
Nyandeyama 144 183 327 6 (1.8)
Nengbema* 153 197 350 0 (0.0)
Mendewa 126 160 286 0 (0.0)
Total 587 726 1313 9 (0.7)
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Statistical analysis
Infection in the vector population was calculated using the
Poolscreen v2.0 [28] to determine the maximum likelihood
of infection together with the associated 95 % CIs. From
the ICT and TAS survey, the prevalence (%) of antigenemia
and microfilaremia was calculated as the number of positive
people divided by the number of people examined.
Results
The cross sectional surveys revealed that out of the six
communities surveyed in Pujehun district, three were
positive for W. bancrofti infection using ICT cards
(Table 1). In Bo, two communities out of four were
positive for antigen. The total antigen prevalence in the
districts was 0.3 % (5/1542) and 0.7 % (9/1313) in the
Pujehun and Bo districts respectively.
Following the TAS protocol, ten antigen and four MF
positive children were identified in the Pujehun district
(Table 2) [25], while only three antigen positive children
were detected in Bo. No MF positive children were de-
tected in Bo. The antigen levels following the school
cluster surveys were 0.67 % and 0.16 % in Pujehun and
Bo respectively. Despite the antigen levels being below
the recommended prevalence for stopping MDA in the
districts, antigen levels were ≥ 2 % in some of the school
clusters used in the TAS protocol (Table 3).
The entomological surveys revealed that low num-
bers of An. gambiae were caught in the study villages
and processed for W. bancrofti infection (Table 4). In
Pujehun, a total of 259 An. gambiae mosquitoes were
processed for W. bancrofti infection in 21 pools (pool
range 3–20). Despite the low numbers of mosquitoes
collected and processed, molecular xenomonitoring
revealed two pools positive for W. bancrofti DNA,
with a Maximum Likelihood Infection (MLI) estimate
of 0.79 % (Table 4), in communities where antigen
positive individuals were identified (Fig. 1). In Bo, 791
mosquitoes were collected and no positive mosquitoes
were detected. The ITN usage in the districts was also
estimated to be 66.1 % (193/292) in Pujehun and
49.3 % (621/1260) in Bo.
Discussion
The results of the antigen prevalence survey revealed that
levels were below the thresholds that signify sustainable
transmission [25]. However, it is worth mentioning that
Table 4 Xenomonitoring results from Pujehun and Bo Districts
Districts Sites ITN Usage (%) No. of mosquitoes No. of pools Pools positive (MLI %) 95 % CI
Pujehun Sahn Malen 30/59 (50.8) 65 5 0 -
Karlu* 22/37 (59.5) 75 5 1 (1.42) 0.044 - 7.1
Gbondapi 31/46 (67.4) 18 2 0 -
Sumbuya Bessima 35/73 (47.9) 14 2 0 -
Kundorwahun 42/44 (95.5) 36 2 0 -
Vaama 33/33 (100.0) 51 5 1 (2.04) 0.064 - 10.1
Total 193/292 (66.1) 259 21 2 (0.79) 0.094 - 2.76
Bo Njala Komboya 53/146 (36.3) 135 8 0 -
Nyandeyama 213/343 (62.1) 492 26 0 -
Nengbema 174/232 (75.0) 80 5 0 -
Mendewa 181/539 (33.6) 84 6 0 -
Total 621/1260 (49.3) 791 45 0 -
Table 3 School clusters positive during the TAS survey
Names of schools Town/Village Total Tested No. of Ag. Positives (%) No. of MF Positives (%)
Pujehun Roman Catholic school Potoru-Zimmi Rd 50 3 (6.0) 2 (4.0)
United Muslim Association Tongay/Pujehun 42 3 (7.1 %) 0
SLC Primary School Boma 50 1 (2.0) 1 (2.0)
SLC Primary School Karlu* 50 1 (2.0) 1 (2.0)
SLC Primary School Mano Gbojeima 50 1 (2.0) 0
Roman Catholic school Zimmi Makpele 50 1 (2.0) 0
Bo S.D.A. Samamie Bo 59 1 (1.7) 0
UMC Jembeh Jembeh 52 1 (1.9) 0
UMC Primary School Benduma 49 1 (2.0) 0
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even though the antigen levels were below the recom-
mended levels for the entire districts, antigen levels were ≥
2 % in some of the school clusters used in the TAS proto-
col, with similar observations made in Sri Lanka and
Zanzibar [5, 29]. During the mapping surveys in 2008,
Pujehun was one of the districts with low endemicity of
antigenemia (4 %), with no microfilaria detected [10].
Nonetheless, our study revealed the existence of areas
with residual transmission in Pujehun district with
evidence of active but highly focal transmission of LF
through the detection of MF in children and uptake of
MF by LF vectors. While areas of residual transmission
may be termed as hotspots, it is important to clearly
establish what can be considered a hotspot in LF trans-
mission. We considered a hotspot to be: 1. an area
where MF carriers persisted after 3 or more rounds of
MDA when the sentinel site prevalence is less than 1 %;
2. school clusters with antigen prevalence of > 2 % in
6–7 year olds, following TAS. The existence of areas
of residual transmission in Pujehun District (Fig. 1)
illustrates the focality of Anopheles-transmitted LF
and challenges faced in selecting high risk areas for
sentinel site and spot check surveys, and the need
for adopting more statistically robust sampling strat-
egies and reviewing the size of the evaluation unit
for TAS [4].
Fig. 1 Map of survey sites in Pujehun District
Fig. 2 Modification of the WHO recommendation [1] for timing of sentinel and spot-check site assessments in national programmes. * Likely, but
not necessary, to be conducted regardless of assessment results
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The low numbers of mosquitoes collected in the study
areas is probably the result of the high ITN usage in the
study areas (66.1 % and 49.3 % in Pujehun and Bo respect-
ively). There has been an increased use of insecticide
treated nets through mass ITN distribution campaigns in
Sierra Leone and in the Pujehun and Bo Districts [12, 13].
By 2010, 67.2 % LLIN usage was reported in the study
areas [13]. Prior to this, the use of ITN has never been
tried in forest zones, and the introduction of ITN in Bo
district followed earlier studies to evaluate the Anopheline
ecology and behaviour, to understand the role of the
vectors in malaria epidemiology and formulate appropri-
ate strategies for the area [30–33].
The detection of positive mosquitoes in areas positive
for antigen in humans indicates possible on-going trans-
mission, and similar results have been obtained in the
American Samoa [34]. These results support the evidence
that molecular xenomonitoring can be an effective tool in
post-MDA surveillance [5, 34]. While there is currently no
existing target threshold for monitoring parasite DNA
prevalence in Anopheline vectors [5, 35], 0.25 % has been
suggested as the maximum infection prevalence expected
to sustain transmission by Culex species [5]. Studies are
required to determine cut-off threshold for Anopheles
mosquitoes. Further, given that Culex mosquitoes are
more efficient LF vectors than Anopheles, we advocate the
establishment for different cut-offs for these species by
TAS, as the current algorithm for choosing TAS design is
similar in areas where LF is transmitted by Anopheles and
Culex species [24].
In Sierra Leone, as in the other countries in West
Africa, lymphatic filariasis is transmitted by the malaria
carrying Anopheles mosquitoes and Culex species play
little or no role in the transmission of the disease [18].
Very early studies elsewhere have shown that where LF
transmission by Anopheles mosquitoes was interrupted
through vector control alone, transmission never resumed.
The control of vectors through house-spraying with
residual insecticides resulted in the sustained interruption
of LF by the Anopheles punctulatus group in Solomon
Islands [36] and parts of Papua New Guinea [37], and
cases of LF resurgence only detected in countries where
Culex mosquitoes were the vectors, including Zanzibar in
United Republic of Tanzania [7, 8, 29]. As suggested by
Webber, vector biting rates of Anopheline mosquitoes less
than 0.66 bites/man/h are unlikely to sustain the transmis-
sion of LF [36], and malaria control efforts targeting the
Anopheles mosquito therefore have the potential to impact
LF transmission in Africa [23, 38], except in areas where
some species of Anopheline mosquitoes have the potential
to exhibit the phenomenon of limitation [39, 40]. As such,
what is the significance of areas of residual transmission
on the elimination of LF? Studies elsewhere, including
Mali in West Africa, have shown that the existence of
areas of possible transmission did not result in resurgence
of the disease [36, 37, 41]. Before China was certified free
of LF in 2007, studies had shown that despite the presence
of residual MF prevalence in the population, transmission
was considered to have been interrupted [42, 43]. This
does lead us to operate on the hypothesis that the thresh-
old for active transmission of LF in areas where Anopheles
mosquitoes exhibit facilitation is higher compared to areas
where Culex mosquitoes are principal vectors. As such,
these observations bring into question the importance of
areas with residual infections on the elimination of LF.
Conclusion
From this study and other reports from elsewhere, we
conclude that the existence of areas of residual transmis-
sion will not necessarily lead to the spread of Anopheles
transmitted LF infection, where the vectors exhibit facili-
tation. What should be emphasized is the value of xeno-
monitoring in determining if ongoing vector control
activities, biting rates and infection rates of the vectors
can support the transmission of the disease. Additional
control strategies may then be implemented based on
the evidence obtained from the xenomonitoring surveys
in these areas. Furthermore, it may not be necessary to
complete the minimum 5 rounds of MDA before imple-
menting TAS, when mid-term assessments reveal MF
prevalence below 1 % or 2 % antigen level, in Anopheles
transmission areas with active and effective malaria vector
control efforts. Implementing 2 additional rounds of
MDA before TAS in these areas will require significant
resources that can better be directed to other areas with
more pressing needs. Thus we propose a modification
(Fig. 2) of the WHO recommendation for the timing of
sentinel and spot-check site assessments in national pro-
grams [1], depending on whether LF endemic areas have a
history of Ivermectin treatment and/or implement vector
control strategies which may differ in various countries,
through ITN/LLIN distribution or Indoor Residual Spray.
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